Kari Brown
About Kari Brown
Kari Brown serves as the Senior Medical Director of Clinical Science at Aimmune Therapeutics, where she has worked since 2020. With a strong background in allergy and immunology, she has extensive experience in clinical trials and holds degrees from Emory University.
Current Role at Aimmune Therapeutics
Kari Brown serves as the Senior Medical Director of Clinical Science at Aimmune Therapeutics, a position she has held since 2020. In this role, she is responsible for overseeing clinical research and development initiatives within the company. Her work focuses on advancing therapeutic innovations and ensuring the implementation of evidence-based medical practices. Brown is based in the Raleigh-Durham, North Carolina area.
Previous Experience at Aimmune Therapeutics
Before her current role, Kari Brown worked as a Medical Director at Aimmune Therapeutics from 2017 to 2020. During her tenure, she contributed to the development and management of clinical trials, enhancing the company's research capabilities in the field of allergy and immunology.
Educational Background
Kari Brown has a robust educational background in medicine and science. She earned her Doctor of Medicine (MD) from Emory University School of Medicine, completing her studies from 2006 to 2011. Additionally, she obtained a Master of Science (MS) from Emory University in 2010, following her Bachelor of Science (BS) degree from the same institution, which she completed in 2006.
Clinical Training and Fellowships
Kari Brown completed her Pediatric Residency at Vanderbilt University from 2011 to 2014. Following this, she pursued a fellowship in Allergy and Immunology at Cincinnati Children's Hospital Medical Center from 2014 to 2016. These experiences provided her with extensive clinical training and expertise in managing complex allergic conditions.
Professional Certifications and Advocacy
Kari Brown is board certified in allergy and immunology, reflecting her specialized knowledge in this area. She advocates for evidence-based medical care and is committed to advancing innovation within the medical field. Her focus on clinical trials and research underscores her dedication to improving patient outcomes through scientific advancements.